Hybrigenics Services
Protein interaction screening and nanobody discovery services for pharmaceutical, biotech and academic researchers
Highlights
- New on EvolcAdded 2026-10-30
About Hybrigenics Services
Hybrigenics Services provides yeast two-hybrid screening for protein, drug-target and small-molecule-induced interactions, as well as custom VHH nanobody selection, validation and affinity maturation.
Its customers include pharmaceutical and biotech companies, academic researchers and other scientific partners. It operates as a fee-for-service R&D provider.
The company was founded in 2009 and is headquartered in Évry-Courcouronnes, France. It moved its laboratories to the Genopole biotech hub in 2019 and serves clients worldwide.
Product: Fee-for-service protein interaction screening, drug-target discovery and custom VHH nanobody selection and validation.
Jobs at Hybrigenics Services
Leadership
- Jean-Christophe Rain · CEO and CSOSource: company website
More biotech & pharma companies
Hyphen Biomed
In-vitro diagnostic reagents for thrombosis and hemostasis testing, sold to hospital labs, researchers and pharma worldwideNew on EvolcIbsa Pharma
French subsidiary of pharma group IBSA, marketing medicines across 10 therapeutic areas in FranceNew on EvolcIconeus
Functional ultrasound brain imaging systems for preclinical neuroscience researchers, with clinical research useNew on EvolcIctyodev
Animal health laboratory developing vaccine adjuvants, tilapia health products and diagnostic services for animal health companiesNew on EvolcId Solutions
Molecular research and diagnostic tools for oncology and infectious disease laboratoriesNew on EvolcIdmed
Medical devices for anesthesia and intensive care monitoring, such as pupillometry and neuromuscular blockade monitorsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Google Ads
- Google Analytics 4
- Google Tag Manager
- Google Universal Analytics
- HubSpot
- HubSpot CMS
- jQuery